Alloimmunization to D antigen and HLA in D‐negative immunosuppressed oncology patients

Transfusion

Volumn 28, Issue 4, 1988, Pages 330-333

  Kickler, T S ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY;

ALLOIMMUNIZATION; BLOOD TRANSFUSION; CANCER; CLINICAL ARTICLE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIBODY FORMATION; ANTILYMPHOCYTE SERUM; DRUG THERAPY; FEMALE; HLA ANTIGENS; HUMAN; IMMUNE TOLERANCE; ISOANTIBODIES; LEUKEMIA; MALE; MIDDLE AGE; RH-HR BLOOD-GROUP SYSTEM;

EID: 0023774682     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1988.28488265260.x     Document Type: Article

References (10)

1. Rh‐incompatible platelet transfusions: risks and consequences of sensitizing immunosuppressed patients
2. Rh‐incompatible platelet transfusion therapy in cancer patients: a study of 30 patients
3. Suppression of transfusion‐related alloimmunization in intensively treated cancer patients
4. Schiffer C, Aisner J, Wiernik P. Long‐term follow‐up of patients with leukemia receiving platelet transfusions: identification of a large group of patients who do not become alloimmunized
5. On the incidence of second antibody populations in the sera of women who have developed anti‐Rh antibodies
6. HL‐A phenotype and anti‐RhD(D) immunization
7. Incidence of lymphocytotoxic antibody in maternal serum at delivery, in cord serum and placental fluid
8. Plasma cell myeloma